JP2024528202A5 - - Google Patents

Info

Publication number
JP2024528202A5
JP2024528202A5 JP2024506631A JP2024506631A JP2024528202A5 JP 2024528202 A5 JP2024528202 A5 JP 2024528202A5 JP 2024506631 A JP2024506631 A JP 2024506631A JP 2024506631 A JP2024506631 A JP 2024506631A JP 2024528202 A5 JP2024528202 A5 JP 2024528202A5
Authority
JP
Japan
Prior art keywords
target sequence
cells
rna guide
gene
grna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528202A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074423 external-priority patent/WO2023015182A1/en
Publication of JP2024528202A publication Critical patent/JP2024528202A/ja
Publication of JP2024528202A5 publication Critical patent/JP2024528202A5/ja
Pending legal-status Critical Current

Links

JP2024506631A 2021-08-02 2022-08-02 遺伝子修飾のための組成物及び方法 Pending JP2024528202A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163228548P 2021-08-02 2021-08-02
US63/228,548 2021-08-02
US202163229484P 2021-08-04 2021-08-04
US63/229,484 2021-08-04
US202263341346P 2022-05-12 2022-05-12
US63/341,346 2022-05-12
US202263346819P 2022-05-27 2022-05-27
US63/346,819 2022-05-27
PCT/US2022/074423 WO2023015182A1 (en) 2021-08-02 2022-08-02 Compositions and methods for gene modification

Publications (2)

Publication Number Publication Date
JP2024528202A JP2024528202A (ja) 2024-07-26
JP2024528202A5 true JP2024528202A5 (cg-RX-API-DMAC7.html) 2025-08-13

Family

ID=83558256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506631A Pending JP2024528202A (ja) 2021-08-02 2022-08-02 遺伝子修飾のための組成物及び方法

Country Status (6)

Country Link
US (1) US20250122534A1 (cg-RX-API-DMAC7.html)
EP (1) EP4381062A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024528202A (cg-RX-API-DMAC7.html)
AU (1) AU2022324093A1 (cg-RX-API-DMAC7.html)
CA (1) CA3228272A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023015182A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3110837A1 (en) 2018-08-28 2020-03-05 Vor Biopharma Inc. Genetically engineered hematopoietic stem cells and uses thereof
WO2024073751A1 (en) 2022-09-29 2024-04-04 Vor Biopharma Inc. Methods and compositions for gene modification and enrichment
WO2025030010A1 (en) 2023-08-01 2025-02-06 Vor Biopharma Inc. Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
EP3129485B2 (en) 2014-04-09 2022-12-21 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating cystic fibrosis
CA2969619A1 (en) 2014-12-03 2016-06-09 Agilent Technologies, Inc. Guide rna with chemical modifications
CN107787367B (zh) 2015-04-06 2021-10-26 里兰斯坦福初级大学理事会 用于crispr/cas介导的基因调控的化学修饰的引导rna
GB201506509D0 (en) 2015-04-16 2015-06-03 Univ Wageningen Nuclease-mediated genome editing
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2017035388A2 (en) 2015-08-25 2017-03-02 Snooz, Llc Machine and method for acoustic white noise generation
IL258491B2 (en) 2015-10-16 2023-09-01 Univ Columbia Preparations and methods for inhibiting antigens of a particular lineage
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP3426784A1 (en) 2016-03-11 2019-01-16 Wageningen Universiteit Improved crispr-cpf1 genome editing tool
KR20260004568A (ko) 2016-04-19 2026-01-08 더 브로드 인스티튜트, 인코퍼레이티드 신규한 crispr 효소 및 시스템
EP3448995A1 (en) 2016-04-25 2019-03-06 Universität Basel Allele editing and applications thereof
US10767175B2 (en) 2016-06-08 2020-09-08 Agilent Technologies, Inc. High specificity genome editing using chemically modified guide RNAs
US11466291B2 (en) * 2016-07-06 2022-10-11 Cellectis Sequential gene editing in primary immune cells
US20190365806A1 (en) 2016-11-02 2019-12-05 Universität Basel Immunologically discernible cell surface variants for use in cell therapy
GB201618507D0 (en) 2016-11-02 2016-12-14 Stichting Voor De Technische Wetenschappen And Wageningen Univ Microbial genome editing
CA3044101A1 (en) 2016-11-22 2018-05-31 Integrated Dna Technologies, Inc. Crispr/cpf1 systems and methods
CN110249052B (zh) 2016-12-30 2024-04-12 爱迪塔斯医药公司 合成的指导分子、组合物和与其相关的方法
CN110914310A (zh) 2017-03-10 2020-03-24 哈佛大学的校长及成员们 胞嘧啶至鸟嘌呤碱基编辑器
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
AU2018383712B2 (en) 2017-12-11 2025-09-04 Editas Medicine, Inc. Cpf1-related methods and compositions for gene editing
US12359223B2 (en) * 2018-01-30 2025-07-15 Editas Medicine, Inc. Systems and methods for modulating chromosomal rearrangements
CN111699254A (zh) * 2018-02-08 2020-09-22 齐默尔根公司 使用crispr在棒状杆菌属中进行基因组编辑
US20210017277A1 (en) 2018-03-14 2021-01-21 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Anti-cd33 chimeric antigen receptors and their uses
CA3110837A1 (en) * 2018-08-28 2020-03-05 Vor Biopharma Inc. Genetically engineered hematopoietic stem cells and uses thereof
US20200216825A1 (en) 2019-01-08 2020-07-09 Integrated Dna Technologies, Inc. CAS12a MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
JP7784707B2 (ja) 2019-01-16 2025-12-12 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 系統特異的抗原の阻害のための組成物および方法
CN113811608B (zh) 2019-02-22 2024-10-29 合成Dna技术公司 毛螺菌科细菌nd2006 cas12a突变型基因和由其编码的多肽
AU2020280103A1 (en) 2019-05-23 2021-12-23 Vor Biopharma Inc. Compositions and methods for CD33 modification
WO2021041977A1 (en) 2019-08-28 2021-03-04 Vor Biopharma, Inc. Compositions and methods for cd123 modification
AU2020338011A1 (en) 2019-08-28 2022-03-10 Vor Biopharma Inc. Compositions and methods for CLL1 modification
KR20230017783A (ko) * 2020-04-28 2023-02-06 인텔리아 테라퓨틱스, 인크. 시험관내 세포 전달 방법

Similar Documents

Publication Publication Date Title
US12214022B2 (en) Sequence-specific antimicrobials by blocking DNA repair
Enyeart et al. Generalized bacterial genome editing using mobile group II introns and Cre-lox
AU2025203777A9 (en) CRISPR-Cas component systems, methods and compositions for sequence manipulation
JP2023541457A5 (cg-RX-API-DMAC7.html)
CN114075559B (zh) 一种2型CRISPR/Cas9基因编辑系统及其应用
AU2016244241A1 (en) Engineering of systems, methods and optimized guide compositions for sequence manipulation
AU2018341985A1 (en) CRISPR/Cas system and method for genome editing and modulating transcription
RS60492B1 (sr) Multipleksirani genomski inženjering omogućen pomoću crispr
JP2022534813A5 (cg-RX-API-DMAC7.html)
US20240132873A1 (en) Site-specific genome modification technology
Chandran et al. TREC-IN: gene knock-in genetic tool for genomes cloned in yeast
Erdmann et al. SMV1 virus-induced CRISPR spacer acquisition from the conjugative plasmid pMGB1 in Sulfolobus solfataricus P2
JP2023541458A5 (cg-RX-API-DMAC7.html)
George et al. Repair of double-strand breaks in bacteriophage T4 by a mechanism that involves extensive DNA replication
JP2026035762A5 (cg-RX-API-DMAC7.html)
Takahashi et al. Genetic recombination through double-strand break repair: shift from two-progeny mode to one-progeny mode by heterologous inserts
EauClaire et al. A CRISPR/Cas9 method to generate heterozygous alleles in Saccharomyces cerevisiae
JP2023121643A (ja) II型CRISPR/Cas9遺伝子編集システムとその応用
JP2023550355A5 (cg-RX-API-DMAC7.html)
Haider et al. Fully Transient CRISPR/Cas12f system in plants capable of broad-spectrum resistance against Begomovirus
Palanivelu Assessment and Analyses of Homing Endonucleases and Mechanism of Action of CRISPR-Cas9 HNH Endonucleases
JP2023538537A (ja) 核酸の標的化除去のための方法
Petsche Construction of a target-specific CRISPR-Cas9 vector for the purpose of introducing mutations into the FUM1 gene of Fusarium verticillioides
JPS6054683A (ja) 新規dνa及びハイブリツドdνa
CN101311185A (zh) 一种基于半推理设计的基因体外定向进化体系